Shargorodsky M et al., “Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors, and inflammatory markers in patients with multiple cardiovascular risk factors,” Nutrition & Metabolism, vol. 7, no. 55 (July 2010).
In this study, researchers evaluated the antioxidant effects of prolonged supplementation with coenzyme Q10 (CoQ10), selenium, and vitamins C and E on arterial elasticity, inflammatory, and metabolic measures in patients deemed as having multiple cardiovascular risk factors.
The randomized, placebo-controlled trial was performed over six months on 70 patients with at least two cardiovascular risk factors. (Risk factors were defined by the National Cholesterol Education Program’s risk factor categories, which include hypertension, diabetes, hypertriglyceridemia, low levels of high-density lipoprotein, and cigarette smoking.)
Subjects were divided into two groups. One group orally supplemented with two capsules per day containing 500 mg of vitamin C, 200 IU of vitamin E, 60 mg of CoQ10, and 100 mcg of selenium.
The researchers determined that the antioxidants significantly increased large and small artery elasticity. Other benefits included an improvement in glucose and lipid metabolism, as well as a decrease in blood pressure.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.